Open Access BASE2019

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial

von Seidlein, Lorenz; Peto, Thomas; Landier, Jordi; Nguyen, Thuy-Nhien; Tripura, Rupam; Phommasone, Koukeo; Pongvongsa, Tiengkham; Lwin, Khin; Keereecharoen, Lilly; Kajeechiwa, Ladda; Thwin, May; Parker, Daniel; Wiladphaingern, Jacher; Nosten, Suphak; Proux, Stephane; Corbel, Vincent; Tuong-Vy, Nguyen; Le Phuc-Nhi, Truong; Son, Do; Nguyen Huong-Thu, Pham; Tuyen, Nguyen Thi Kim; Tien, Nguyen; Dong, Le; van Hue, Dao; Quang, Huynh Hong; Nguon, Chea; Davoeung, Chan; Rekol, Huy; Adhikariid, Bipin; Henriques, Gisela; Phongmany, Panom; Suangkanarat, Preyanan; Jeeyapant, Atthanee; Vihokhern, Benchawan; van Der Pluijm, Rob; Lubell, yoel; White, Lisa; Aguas, Ricardo; Promnarate, Cholrawee; Sirithiranont, Pasathorn; Malleret, Benoit; Rénia, Laurent; Onsjö, Carl; Chan, Xin; Chalk, Jeremy; Miotto, Olivo; Patumrat, Krittaya; Chotivanich, Kesinee; Hanboonkunupakarn, Borimas; Jittmala, Podjanee

Zugriff(Open Access)

Abstract

International audience ; BACKGROUND:The emergence and spread of multidrug-resistant Plasmodium falciparum in the Greater Mekong Subregion (GMS) threatens global malaria elimination efforts. Mass drug administration (MDA), the presumptive antimalarial treatment of an entire population to clear the subclinical parasite reservoir, is a strategy to accelerate malaria elimination. We report a cluster randomised trial to assess the effectiveness of dihydroartemisinin-piperaquine (DP) MDA in reducing falciparum malaria incidence and prevalence in 16 remote village populations in Myanmar, Vietnam, Cambodia, and the Lao People's Democratic Republic, where artemisinin resistance is prevalent.METHODS AND FINDINGS:After establishing vector control and community-based case management and following intensive community engagement, we used restricted randomisation within village pairs to select 8 villages to receive early DP MDA and 8 villages as controls for 12 months, after which the control villages received deferred DP MDA. The MDA comprised 3 monthly rounds of 3 daily doses of DP and, except in Cambodia, a single low dose of primaquine. We conducted exhaustive cross-sectional surveys of the entire population of each village at quarterly intervals using ultrasensitive quantitative PCR to detect Plasmodium infections. The study was conducted between May 2013 and July 2017. The investigators randomised 16 villages that had a total of 8,445 residents at the start of the study. Of these 8,445 residents, 4,135 (49%) residents living in 8 villages, plus an additional 288 newcomers to the villages, were randomised to receive early MDA; 3,790 out of the 4,423 (86%) participated in at least 1 MDA round, and 2,520 out of the 4,423 (57%) participated in all 3 rounds. The primary outcome, P. falciparum prevalence by month 3 (M3), fell by 92% (from 5.1% [171/3,340] to 0.4% [12/2,828]) in early MDA villages and by 29% (from 7.2% [246/3,405] to 5.1% [155/3,057]) in control villages. Over the following 9 months, the P. falciparum ...